solifenacin/tamsulosin "newbury" 6+0,4 mg tabletter med modificeret udløsning
newbury pharmaceuticals ab - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg
zulvac 1+8 bovis
zoetis belgium sa - inaktiverede bluetongue virus, serotype 1, stamme btv-1/alg2006/01 e1 rp, inaktiveret, bluetongue virus, serotype 8, stamme btv-8/bel2006/02 - bluetongue virus, immunologicals, immunologicals for bovidae, kvæg, inaktiveret, viral vacciner - kvæg - aktiv immunisering af kvæg fra 3 måneder for forebyggelse * af viraæmi forårsaget af bluetongue virus (btv), serotyper 1 og 8. * (cykelværdi (ct) ≥ 36 ved en valideret rt-pcr-metode, der indikerer ingen tilstedeværelse af virusgenomet).
crestor 5 mg filmovertrukne tabletter
2care4 aps - rosuvastatin calcium - filmovertrukne tabletter - 5 mg
lipocomb 10+10 mg kapsler, hårde
egis pharmaceuticals plc - ezetimib, rosuvastatin zinc - kapsler, hårde - 10+10 mg
lipocomb 20+10 mg kapsler, hårde
egis pharmaceuticals plc - ezetimib, rosuvastatin zinc - kapsler, hårde - 20+10 mg
lipocomb 40+10 mg kapsler, hårde
egis pharmaceuticals plc - ezetimib, rosuvastatin zinc - kapsler, hårde - 40+10 mg
alunbrig
takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
alcartis 10 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 10 mg
alcartis 15 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 15 mg
alcartis 30 mg smeltetabletter
egis pharmaceuticals plc - aripiprazol - smeltetabletter - 30 mg